Security key
426897104
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA)
CUSIP: 426897104
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 29,123,952
- Total 13F shares
- 155,684
- Share change
- +155,684
- Total reported value
- $377,000
- Price per share
- $2.43
- Number of holders
- 4
- Value change
- +$377,000
- Number of buys
- 4
Report period
Q3 2019
Institutions
4
Top holders
4
HEPA full security history
Newer quarter: Q4 2019
Hepion Pharmaceuticals, Inc. SEC filings
Hepion Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 426897104
Recent filing periods:
Top shareholders of HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q3 2019
As of 30 Sep 2019,
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
155,684 shares.
The largest 4 holders included
SABBY MANAGEMENT, LLC, A.R.T. Advisors, LLC, Virtu Financial LLC, and UBS Group AG.
This page lists
4
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q1 2023 Across Filers
Q1 2023 holders
7
Q3 2019 holders
4
Holder diff
-3
| Investor | Q1 2023 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.